Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

Platinum Press Inc. (PPI) has commenced runs utilizing a digital printing system whose inks are free of volatile organic ...

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.

Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.